Skip to main content
logo
IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
32.18
-1.01 (-3.04%)
At close: Oct 29, 2025, 4:00 PM EDT
31.67
-0.51 (-1.59%)
After-hours: Oct 29, 2025, 7:38 PM EDT

IDEAYA Biosciences Revenue

IDEAYA Biosciences had revenue of $7.00M in the twelve months ending June 30, 2025, down -41.48% year-over-year. In the year 2024, IDEAYA Biosciences had annual revenue of $7.00M, down -70.07%.

Revenue (ttm)
$7.00M
Revenue Growth
-41.48%
P/S Ratio
402.91
Revenue / Employee
$53,435
Employees
131
Market Cap
2.82B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20247.00M-16.39M-70.07%
Dec 31, 202323.39M-27.55M-54.08%
Dec 31, 202250.93M22.99M82.28%
Dec 31, 202127.94M8.40M43.01%
Dec 31, 202019.54M--
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG56.37B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings

IDYA News

More News